689 related articles for article (PubMed ID: 15064394)
21. Identification and functional characterization of a novel R621C mutation in the synphilin-1 gene in Parkinson's disease.
Marx FP; Holzmann C; Strauss KM; Li L; Eberhardt O; Gerhardt E; Cookson MR; Hernandez D; Farrer MJ; Kachergus J; Engelender S; Ross CA; Berger K; Schöls L; Schulz JB; Riess O; Krüger R
Hum Mol Genet; 2003 Jun; 12(11):1223-31. PubMed ID: 12761037
[TBL] [Abstract][Full Text] [Related]
22. NUB1 suppresses the formation of Lewy body-like inclusions by proteasomal degradation of synphilin-1.
Tanji K; Tanaka T; Mori F; Kito K; Takahashi H; Wakabayashi K; Kamitani T
Am J Pathol; 2006 Aug; 169(2):553-65. PubMed ID: 16877356
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
[TBL] [Abstract][Full Text] [Related]
24. The proteasomal subunit S6 ATPase is a novel synphilin-1 interacting protein--implications for Parkinson's disease.
Marx FP; Soehn AS; Berg D; Melle C; Schiesling C; Lang M; Kautzmann S; Strauss KM; Franck T; Engelender S; Pahnke J; Dawson S; von Eggeling F; Schulz JB; Riess O; Krüger R
FASEB J; 2007 Jun; 21(8):1759-67. PubMed ID: 17327361
[TBL] [Abstract][Full Text] [Related]
25. Immunocytochemical localization of synphilin-1, an alpha-synuclein-associated protein, in neurodegenerative disorders.
Wakabayashi K; Engelender S; Tanaka Y; Yoshimoto M; Mori F; Tsuji S; Ross CA; Takahashi H
Acta Neuropathol; 2002 Mar; 103(3):209-14. PubMed ID: 11907799
[TBL] [Abstract][Full Text] [Related]
26. The PINK1, synphilin-1 and SIAH-1 complex constitutes a novel mitophagy pathway.
Szargel R; Shani V; Abd Elghani F; Mekies LN; Liani E; Rott R; Engelender S
Hum Mol Genet; 2016 Aug; 25(16):3476-3490. PubMed ID: 27334109
[TBL] [Abstract][Full Text] [Related]
27. Synphilin-1 is present in Lewy bodies in Parkinson's disease.
Wakabayashi K; Engelender S; Yoshimoto M; Tsuji S; Ross CA; Takahashi H
Ann Neurol; 2000 Apr; 47(4):521-3. PubMed ID: 10762166
[TBL] [Abstract][Full Text] [Related]
28. Dorfin localizes to the ubiquitylated inclusions in Parkinson's disease, dementia with Lewy bodies, multiple system atrophy, and amyotrophic lateral sclerosis.
Hishikawa N; Niwa J; Doyu M; Ito T; Ishigaki S; Hashizume Y; Sobue G
Am J Pathol; 2003 Aug; 163(2):609-19. PubMed ID: 12875980
[TBL] [Abstract][Full Text] [Related]
29. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
[TBL] [Abstract][Full Text] [Related]
30. Pro-apoptotic protein glyceraldehyde-3-phosphate dehydrogenase promotes the formation of Lewy body-like inclusions.
Tsuchiya K; Tajima H; Kuwae T; Takeshima T; Nakano T; Tanaka M; Sunaga K; Fukuhara Y; Nakashima K; Ohama E; Mochizuki H; Mizuno Y; Katsube N; Ishitani R
Eur J Neurosci; 2005 Jan; 21(2):317-26. PubMed ID: 15673432
[TBL] [Abstract][Full Text] [Related]
31. [The mechanism of Lewy body formation in Parkinson's disease].
Wakabayashi K; Takahashi H
Nihon Rinsho; 2000 Oct; 58(10):2022-7. PubMed ID: 11068441
[TBL] [Abstract][Full Text] [Related]
32. Interaction with synphilin-1 promotes inclusion formation of alpha-synuclein: mechanistic insights and pathological implication.
Xie YY; Zhou CJ; Zhou ZR; Hong J; Che MX; Fu QS; Song AX; Lin DH; Hu HY
FASEB J; 2010 Jan; 24(1):196-205. PubMed ID: 19762560
[TBL] [Abstract][Full Text] [Related]
33. Parkin and defective ubiquitination in Parkinson's disease.
Dawson TM
J Neural Transm Suppl; 2006; (70):209-13. PubMed ID: 17017531
[TBL] [Abstract][Full Text] [Related]
34. Synphilin-1A: an aggregation-prone isoform of synphilin-1 that causes neuronal death and is present in aggregates from alpha-synucleinopathy patients.
Eyal A; Szargel R; Avraham E; Liani E; Haskin J; Rott R; Engelender S
Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5917-22. PubMed ID: 16595633
[TBL] [Abstract][Full Text] [Related]
35. Altered α-synuclein, parkin, and synphilin isoform levels in multiple system atrophy brains.
Brudek T; Winge K; Rasmussen NB; Bahl JM; Tanassi J; Agander TK; Hyde TM; Pakkenberg B
J Neurochem; 2016 Jan; 136(1):172-85. PubMed ID: 26465922
[TBL] [Abstract][Full Text] [Related]
36. Parkin accumulation in aggresomes due to proteasome impairment.
Junn E; Lee SS; Suhr UT; Mouradian MM
J Biol Chem; 2002 Dec; 277(49):47870-7. PubMed ID: 12364339
[TBL] [Abstract][Full Text] [Related]
37. Pathological proteins in Parkinson's disease: focus on the proteasome.
Snyder H; Wolozin B
J Mol Neurosci; 2004; 24(3):425-42. PubMed ID: 15655264
[TBL] [Abstract][Full Text] [Related]
38. Parkin-mediated lysine 63-linked polyubiquitination: a link to protein inclusions formation in Parkinson's and other conformational diseases?
Lim KL; Dawson VL; Dawson TM
Neurobiol Aging; 2006 Apr; 27(4):524-9. PubMed ID: 16213628
[TBL] [Abstract][Full Text] [Related]
39. Aggresome formation and segregation of inclusions influence toxicity of α-synuclein and synphilin-1 in yeast.
Swinnen E; Büttner S; Outeiro TF; Galas MC; Madeo F; Winderickx J; Franssens V
Biochem Soc Trans; 2011 Oct; 39(5):1476-81. PubMed ID: 21936837
[TBL] [Abstract][Full Text] [Related]
40. Pael-R is accumulated in Lewy bodies of Parkinson's disease.
Murakami T; Shoji M; Imai Y; Inoue H; Kawarabayashi T; Matsubara E; Harigaya Y; Sasaki A; Takahashi R; Abe K
Ann Neurol; 2004 Mar; 55(3):439-42. PubMed ID: 14991825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
